Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 4.86-11.939.9461.19-6.83

What is the latest Core EBITDA Growth ratio of EMCURE PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of EMCURE PHARMACEUTICALS is 4.86 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar20244.86
Mar2023-11.93
Mar20229.94
Mar202161.19
Mar2020-6.83

How is Core EBITDA Growth of EMCURE PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 4.86
Positive
Mar2023 -11.93
Negative
Mar2022 9.94
-83.76
Mar2021 61.19
Positive
Mar2020 -6.83 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹18,700.8 Cr -8% 4.7% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹410,142.0 Cr -1.5% 9.1% 9.1% Stock Analytics
DIVIS LABORATORIES ₹145,762.0 Cr -4.9% -0.6% 59.1% Stock Analytics
CIPLA ₹114,322.0 Cr -1.8% 1% 0.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹111,171.0 Cr 1.6% 12.1% 21.8% Stock Analytics
DR REDDYS LABORATORIES ₹92,603.7 Cr -3% -0.9% -7.7% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-8%

4.7%

NA
SENSEX

-2.9%

3.1%

1.8%


You may also like the below Video Courses